Colorectal cancer screening: Will global warming affect the accuracy of FIT testing?

Gut

Volumn 59, Issue 11, 2010, Pages 1451-1452

  Rennert, Gad ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; ENVIRONMENTAL EXPOSURE; GREENHOUSE EFFECT; HUMAN; LABORATORY TEST; NOTE; OCCULT BLOOD; PRIORITY JOURNAL; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SUMMER; TUMOR BLEEDING; COLORECTAL TUMOR; IMMUNOLOGICAL PROCEDURES; MASS SCREENING; METHODOLOGY; STANDARD; TEMPERATURE;

COLORECTAL NEOPLASMS; GLOBAL WARMING; HUMANS; IMMUNOLOGIC TESTS; MASS SCREENING; OCCULT BLOOD; TEMPERATURE;

EID: 78049519532     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.216291     Document Type: Note

References (26)

1. Benson VS, Patnick J, Davies AK, et al. Atkin WS on behalf of the International Colorectal Cancer Screening Network. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357-67.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993;328:1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-71.
5. Jorgensen OD, Kronborg O, Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32.
6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
7. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
8. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-50, W81.
9. Chen WD, Han ZJ, Skoletsky J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005;97:1124-32.
10. Rennert G, Kislitsin D, Brenner DE, et al. Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer. Cancer Lett 2007;253:258-64.
11. Rennert G. Are we getting closer to molecular population screening for colorectal cancer? J Natl Cancer Inst 2009;101:902-3.
12. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-8.
13. Rennert G, Rennert HS, Miron E, et al. Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiology. Biomarkers and Prevention 2001;10:1165-8.
14. Sinatra MA, St John DJ, Young GP. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clin Chem 1999;45:123-6.
15. Rozen P, Knaani J, Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 1999;44:756-60.
16. Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol 2009;24(Suppl 3):S33-42.
17. Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 2010;59:1511-15.
18. http://www.smh.com.au/national/cancer-bungle-recall-20090511-b0kp.html.
19. Davies PS, Bates CJ, Cole TJ, et al. Seasonal and regional differences in preschool children in Great Britain. Eur J Clin Nutr 1999;53:195-8.
20. Metzger KB, Ito K, Matte TD. Summer heat and mortality in New York City: how hot is too hot? Environ Health Perspect 2010;118:80-6.
21. Sebok MA, Notari EP, Chambers LA, et al. Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross. Transfusion 2007;47:890-4.
22. Wang XY, Barnett AG, Hu W, et al. Temperature variation and emergency hospital admissions for stroke in Brisbane, Australia, 1996-2005. Int J Biometeorol 2009;53:535-41.
23. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55.
24. Atkin WS, Edwards R, Kralj-Hans I, et al. UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
25. Brenner H, Hoffmeister M, Arndt V, et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010;102:89-95.
26. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.